Hamilton, Australia · Founded 2011 · Privately Held (backing)
Developer of a needle-free vaccine delivery system designed to enhance the performance of existing and next-generation vaccines. Vaxxas is based in Hamilton, Australia and was founded in 2011. Its last reported valuation was $236 million in Aug 2025. It has raised $154 million.
Last reported valuation
$235.6M
Oct 2026
Priced at
—
Total raised
$154.3M
Last round
—
Team — not yet on record
No current team members for Vaxxas are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vaxxas with a free account
·The complete investor list: 22 names
·Watch Vaxxas: the Monday email on marks, rounds and moves
